Deborah Weitzman, CEO, Pharmaceutical Segment: Cardinal Health CAH Sell · Filed 23/11/29

Trade details

Type: Insider sale
Amount: $3,895,411.02
Shares · price: 36,642 sh · $106.31 a share
Held after: 35,202 sh
Stock: Cardinal Health CAH
Person: Deborah WeitzmanCEO, Pharmaceutical Segment
Trade date: 23/11/27
Filed: 23/11/29
Days to filing: 2 days

Sold 51.0% of holdings

Share of holding sold: 51.0%

Cardinal Health trades, last 26 weeks

What else happened in Cardinal Health around then

Filed or reported within 30 days of the trade day · 23/10/28~23/12/27

Deborah Weitzman's recent trades

Deborah WeitzmanCEO, PSS Segment
Planned saleCardinal Health
Planned sale
Cardinal Health
CAH
$1.7M
7,354 sh
$1.7M
Filed 08/18
Traded 08/18
Deborah WeitzmanCEO, PSS Segment
Planned saleCardinal Health
Planned sale
Cardinal Health
CAH
$3.2M
21,367 sh
$3.2M
Filed 25/08/20
Traded 25/08/20
Deborah WeitzmanCEO, PSS Segment
SellCardinal Health
Sell
Cardinal Health
CAH
$3.2M
21,367 sh
$3.2M
Filed 25/08/20
Traded 25/08/20
Deborah WeitzmanCEO, Pharmaceutical Segment
SellCardinal Health
Sell
Cardinal Health
CAH
$602.8K
6,712 sh
$602.8K
Filed 23/08/29
Traded 23/08/28